Qingdao Haier Biomedical Co.,Ltd Stock: price and insider trades · China
海尔生物
No insider purchase over the last 90 days. The latest, by 江兰, was filed 31 Oct 2024.
Qingdao Haier Biomedical Co.,Ltd: what insiders have been doing
Insider filings for Qingdao Haier Biomedical Co.,Ltd are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 31 October 2024. This page will fill in as new trades are disclosed. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- +13.7%Entry CN¥30.86 · Close at T+365 CN¥35.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 896 shares100.0% of flowA股XSHGSSE:173000008214155400Canonical exit: 29 Jan 2025 (T+90)
1 of 1 declaration
About Qingdao Haier Biomedical Co.,Ltd
Haier Biomedical is a company specializing in the healthcare and pharmaceutical sector, providing innovative solutions for the storage and management of biological samples. It is listed on the Shanghai Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
